PD40-10 EFFECTS OF THE 2012 USPSTF PSA SCREENING RECOMMENDATIONS ON PROSTATE BIOPSY PRACTICES IN AN INNER CITY HOSPITAL WITH A HIGH RISK PATIENT POPULATION

Abstract

You have accessJournal of UrologyProstate Cancer: Detection & Screening V1 Apr 2017PD40-10 EFFECTS OF THE 2012 USPSTF PSA SCREENING RECOMMENDATIONS ON PROSTATE BIOPSY PRACTICES IN AN INNER CITY HOSPITAL WITH A HIGH RISK PATIENT POPULATION Johnathan A. Khusid, Igor Inoyatov, Adan Beccera, Llewellyn Hyacinthe, Brian K. McNeil, and Andrew G. Winer Johnathan A. KhusidJohnathan A. Khusid More articles by this author , Igor InoyatovIgor Inoyatov More articles by this author , Adan BecceraAdan Beccera More articles by this author , Llewellyn HyacintheLlewellyn Hyacinthe More articles by this author , Brian K. McNeilBrian K. McNeil More articles by this author , and Andrew G. WinerAndrew G. Winer More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1750AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In the 2012 US Preventative Services Task Force (USPSTF) recommendation against prostate specific antigen (PSA) screening, it was acknowledged that African American men represented a disproportionately small minority of the population analyzed. We sought to describe the prostate biopsy practice patterns before and after the recommendation in an inner city hospital that serves a high risk patient population of predominantly Afro Caribbean descent. METHODS A retrospective chart review of patients who underwent prostate biopsy from 10/27/2008 to 12/15/2015 was performed. Patients were grouped into those who underwent biopsy prior to, and after the new USPSTF guidelines (5/22/2012). Patient and clinical characteristics were compared between the two time periods. Bivariate analyses included two sample t tests, chi square tests, and the Mann Whitney U tests. RESULTS Our analysis revealed no significant differences in the age, percent of positive biopsies, or type of physician initiating screening. There was a significant difference in median PSA (p= 0.05) and a trend toward significance in the difference in racial distribution between the two groups (p=0.06). Among those with positive biopsies, patients biopsied after the recommendation had significantly greater core positivity, and a borderline significantly higher incidence of clinically significant disease defined by D Amico criteria (p=0.24) CONCLUSIONS In a high risk patient population, we found that men biopsied after the USPSTF recommendation were more likely to have a higher PSA level, more likely to be African American, had greater core positivity, and a higher incidence of clinically significant disease. These results suggest that high risk patients in an inner city setting are also being negatively affected by the implementation of the task force recommendations. Further research is required to determine whether the practice pattern change occurred at the level of PSA screening or rather at patient selection for prostate biopsy. Such research will allow clinicians to provide more granular counseling with regards to PSA screening and prostate biopsies for high risk patients. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e753-e754 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Johnathan A. Khusid More articles by this author Igor Inoyatov More articles by this author Adan Beccera More articles by this author Llewellyn Hyacinthe More articles by this author Brian K. McNeil More articles by this author Andrew G. Winer More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...